
TOM Medications
TOM accelerates the access to a highly engaged and anonymous community of chronic patients to an unprecedented degree.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 Valuation: €0.0 12.8x EV/Revenue | round | |
* | N/A | Grant | |
Total Funding | 000k |
USD | 2022 | 2023 |
---|---|---|
Revenues | 0000 | 0000 |
EBITDA | 0000 | 0000 |
Profit | 0000 | 0000 |
EV | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x |
R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
TOM Medications, operating under the legal name Innovation 6 AG, is a digital health company founded in 2020 by Sven Beichler, who currently serves as CEO. The company's creation was motivated by personal family experiences with illness and the significant healthcare costs associated with poor treatment adherence. Headquartered in Uster, Switzerland, the firm has developed a mobile application to address the widespread issue of medication non-adherence among patients with chronic conditions.
The core of the business is the TOM app, a medication management tool that allows users to create a virtual medicine cabinet, receive reminders for medication intake, track their stock, and monitor health metrics. The platform reports a treatment compliance rate of 83% among its users, a notable increase from the average of 50% for chronic disease patients. The app is free for users and designed to be used anonymously, fostering a large community of active chronic patients, primarily in Switzerland, Germany, and France. Key features include the ability to export health reports for physicians, check for potential drug interactions, and identify double medications. The company emphasizes a user-centric development approach, with 90% of its product updates based on patient feedback.
TOM Medications operates on a B2B model, partnering with pharmaceutical companies, health insurers, and pharmacies. Revenue is generated by providing these partners with access to an anonymized health platform for data analysis on medication adherence and persistence. This data helps industry partners understand patient behavior and improve healthcare outcomes. The company has established significant partnerships, including a pilot project and subsequent investment from health insurance company Sanitas and an investment from Galenica, a major Swiss healthcare service provider. The company has successfully completed multiple funding rounds, including one for over CHF 1.3 million in January 2023, to fuel expansion into new markets and enhance its platform.
Keywords: medication management, treatment adherence, digital health, chronic disease management, mobile health app, patient engagement, pharmaceutical data, health insurance solutions, Galenica, Sanitas, Sven Beichler, medication reminders, virtual medicine cabinet, patient solutions, Swiss startup, health-tech, anonymized health data, therapy monitoring, medication compliance, chronic patient community